I wonder if Bonds and Clemens might make the Hall of Fame this year after all

47 Comments

My strong presumption is that Barry Bonds and Roger Clemens will not make the Hall of Fame this year. I think, at best, they get about 50% of the vote and stay in that limbo-land until the anti-PED crowd’s fever breaks.

But I just read something that makes me wonder if I’m being too pessimistic. It’s a column from Ian O’Connor of ESPN New York in which he takes the “Bonds and Clemens were so good that you have to vote for them even though they juiced” tack. Kind of a “discounter” argument which, while obviously flawed, makes some degree of sense and allows one to differentiate between guys like McGwire and Palmeiro on the one hand — guys who may not have had Cooperstown numbers without PEDs — and Bonds and Clemens on the other, who were gonna make it regardless.

This is somewhat surprising coming from O’Connor, because he has, in the past, given off all the indications of a “PED use = disqualification” kind of guy.  Back in 2010 he demanded that Mets general manager Sandy Alderson offer a public apology for being complicit in allowing “the monstrous steroid culture to grow fangs on his watch.”  Earlier that year he eviscerated Alex Rodriguez as a player who “cheated the game, cheated the fans and cheated himself” and wrote that nothing could “absolve him of his not-so-venial steroid sins.”

I know there is a vast, silent block of Hall of Fame voters who don’t actively write columns and tweet like O’Connor does and who do not, per their job description, think all that much about baseball.  As such, he may not be truly representative of the electorate and thus it may be premature to view O’Connor’s surprising reasonableness about Bonds and Clemens as some sort of harbinger.

But it is interesting. Very, very interesting.

Report: Yankees could be in on Nolan Arenado

Nolan Arenado
Getty Images
Leave a comment

The Yankees appear to have moved on from free agent Manny Machado this winter, but could they be turning their attention to Rockies superstar Nolan Arenado? That’s the idea floated by Andy Martino of SNY, who hears that GM Brian Cashman has been involved in recent discussions concerning the third baseman. No official comments have been made to the press yet, though, and it’s not clear whether the Yankees would prefer to pursue Arenado prior to the 2019 season or partway through it.

The 27-year-old infielder earned his fourth consecutive All-Star nomination, Silver Slugger, and Gold Glove award in 2018 after slashing .297/.374/.561 with 38 home runs, a .935 OPS, and 5.7 fWAR across 673 plate appearances. There’s no question he’s provided immense value to Colorado’s lineup over the last half-decade, and his consistency and incredible power at the plate helped form the basis of the record $30 million arbitration figure he presented to the team last week. The Rockies countered at $24 million, however, and in doing so may have jeopardized their chances of convincing the infielder to forego free agency in 2020 and take a long-term deal instead.

Assuming he declines to negotiate an extension with the Rockies, Arenado’s decorated résumé and career-best 2018 numbers should attract plenty of interest around the league — a reality that could put considerable pressure on the Yankees (or any other interested party) to finesse a deal sooner rather than later. For now, the club is prepared to enter the 2019 season with hot-hitting third baseman Miguel Andújar, whom Martino speculates would be the “centerpiece” of any trade with Colorado.